ATE542810T1 - Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton - Google Patents

Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton

Info

Publication number
ATE542810T1
ATE542810T1 AT07857390T AT07857390T ATE542810T1 AT E542810 T1 ATE542810 T1 AT E542810T1 AT 07857390 T AT07857390 T AT 07857390T AT 07857390 T AT07857390 T AT 07857390T AT E542810 T1 ATE542810 T1 AT E542810T1
Authority
AT
Austria
Prior art keywords
methyl
ribono
lactone
acyl
omikron
Prior art date
Application number
AT07857390T
Other languages
English (en)
Inventor
Miall Cedilote
Thomas P Cleary
Hans Iding
Pingsheng Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE542810T1 publication Critical patent/ATE542810T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07857390T 2006-12-18 2007-12-11 Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton ATE542810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87561706P 2006-12-18 2006-12-18
PCT/EP2007/063703 WO2008074693A2 (en) 2006-12-18 2007-12-11 Process for preparing 3,5-di-omicron-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone

Publications (1)

Publication Number Publication Date
ATE542810T1 true ATE542810T1 (de) 2012-02-15

Family

ID=39433788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07857390T ATE542810T1 (de) 2006-12-18 2007-12-11 Verfahren zur herstellung von 3,5-di-omikron-acyl-2-fluor-2-c-methyl-d-ribono gamma-lacton

Country Status (13)

Country Link
US (1) US7838693B2 (de)
EP (1) EP2094679B1 (de)
JP (1) JP5148627B2 (de)
KR (1) KR101118413B1 (de)
CN (1) CN101573349B (de)
AT (1) ATE542810T1 (de)
AU (1) AU2007336365B2 (de)
BR (1) BRPI0720835A2 (de)
CA (1) CA2671856C (de)
ES (1) ES2379696T3 (de)
IL (1) IL198801A (de)
MX (1) MX2009006156A (de)
WO (1) WO2008074693A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724301A (zh) 2012-10-10 2014-04-16 上海特化医药科技有限公司 (2r)-2-脱氧-2,2-二取代-1,4-核糖内酯及其制备方法和用途
AR094466A1 (es) * 2013-01-14 2015-08-05 Hoffmann La Roche Proceso para la obtención de un derivado de fluorlactona
CN104918924B (zh) * 2013-01-14 2018-05-11 吉利德制药有限责任公司 制备氟代内酯衍生物的方法
CN105026382B (zh) * 2013-02-28 2016-10-19 中央硝子株式会社 (2R)-2-氟-2-C-甲基-D-核糖酸-γ-内酯的制造方法
JP6476591B2 (ja) * 2013-06-05 2019-03-06 セントラル硝子株式会社 (2R)−2−フルオロ−2−C−メチル−D−リボノ−γ−ラクトン類の製造方法
CN105085445B (zh) * 2015-08-11 2016-09-07 海门慧聚药业有限公司 索非布韦中间体的制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030005167A (ko) * 2000-11-30 2003-01-17 다이셀 가가꾸 고교 가부시끼가이샤 전사 시트
US7799827B2 (en) * 2002-03-08 2010-09-21 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
BRPI0419345B8 (pt) * 2003-05-30 2021-05-25 Gilead Pharmasset Llc uso do (2’r)-2’-desoxi-2’-flúor-2’-c-metil nucleosídeo e de uma composição farmacêutica que o compreende
PT1773856E (pt) * 2004-07-21 2012-05-14 Gilead Pharmasset Llc Preparação de 2-desoxi-2-fluoro-d-ribofuranosilo pirimidinas e purinas substituídas com alquilo e seus derivados
MX2007003085A (es) * 2004-09-14 2007-08-02 Pharmasset Inc Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.

Also Published As

Publication number Publication date
ES2379696T3 (es) 2012-04-30
IL198801A (en) 2013-08-29
IL198801A0 (en) 2010-02-17
JP2010513377A (ja) 2010-04-30
MX2009006156A (es) 2009-06-19
CN101573349B (zh) 2013-07-10
CN101573349A (zh) 2009-11-04
JP5148627B2 (ja) 2013-02-20
AU2007336365A1 (en) 2008-06-26
CA2671856A1 (en) 2008-06-26
EP2094679B1 (de) 2012-01-25
US20080145901A1 (en) 2008-06-19
EP2094679A2 (de) 2009-09-02
CA2671856C (en) 2015-02-10
WO2008074693A2 (en) 2008-06-26
WO2008074693A3 (en) 2008-10-30
BRPI0720835A2 (pt) 2015-09-29
KR101118413B1 (ko) 2012-03-07
AU2007336365B2 (en) 2013-03-07
KR20090080562A (ko) 2009-07-24
US7838693B2 (en) 2010-11-23

Similar Documents

Publication Publication Date Title
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
ATE478084T1 (de) Verfahren zur herstellung von 4'- azidocytidinderivaten
ATE444977T1 (de) Verfahren zur herstellung von aba- triblockcopolymeren auf (meth)acrylatbasis
ATE435209T1 (de) Verfahren zur herstellung von montelukast-natrium
DE60311990D1 (de) Verfahren zur herstellung eines virus inaktivierten thrombin präparates
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE527012T1 (de) Verfahren zur herstellung von medizinprodukten mit einer opferstruktur
BRPI0720835A2 (pt) processo para preparação de 3,5-di-omicron-acil-2-fluoro-2-c-metil-d-ribono-gama-lactona
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
ATE404577T1 (de) Verfahren zur herstellung von eplerenon
ATE452894T1 (de) Verfahren zur herstellung von salzen von 4-ää5- ä(cyclopropylamino)carbonylü-2- methylphenylüaminoü-5-methyl-n-propylpyrroloä2, - füä1,2,4ütriazin-6-carboxamid und damit hergestellte neue stabile formen
ATE344273T1 (de) Verfahren zur herstellung von 21-hydroxy-6,19- oxidoprogesteron (21oh-6op)
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
ATE424892T1 (de) Verfahren zur herstellung von derivaten des 4a,5, 9,10,11,12-hexahydrobenzofuro ä3a,3,2üä 2 ü- benzazepins
ATE397611T1 (de) Verfahren zur herstellung von olanzapin
DE60210778D1 (de) Verfahren zur herstellung von 4-amino-2,5-bisheterocyclylchinazolinen
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
ATE496038T1 (de) Verfahren zur herstellung von quetiapin
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
DE602004024152D1 (de) Verfahren zur Herstellung von (Per)fluorhalogenethern
ATE341558T1 (de) Verfahren zur herstellung von topiramate
ATE501104T1 (de) Verfahren zur herstellung von 1,2,2,2-tetrafluor- ethyl-difluor-methylether
DE602006013688D1 (de) Neues verfahren zur herstellung von thoc
ATE380183T1 (de) Verfahren zur herstellung von phenyltetrazolderivaten